Multiple signals in synaptic transmission: impact on the strategies for the development of a new generation of centrally active drugs.
D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000187:drug effects*; D026261:Diazepam Binding Inhibitor; D006801:Humans; D009479:Neuropeptides / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism*; D011619:Psychotropic Drugs / Q000378:metabolism / Q000494:pharmacology*; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D013569:Synapses / Q000187:drug effects*; D009435:Synaptic Transmission / Q000187:drug effects*
D026261:Diazepam Binding Inhibitor; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D011619:Psychotropic Drugs; D017981:Receptors, Neurotransmitter